An observational cohort study in renal cell carcinoma and soft tissue sarcoma patients to identify the number of patients at risk of suboptimal treatment due to low exposure.

Trial Profile

An observational cohort study in renal cell carcinoma and soft tissue sarcoma patients to identify the number of patients at risk of suboptimal treatment due to low exposure.

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Jan 2018

At a glance

  • Drugs Pazopanib (Primary)
  • Indications Leiomyosarcoma; Nerve sheath neoplasms; Renal cell carcinoma; Soft tissue sarcoma; Synovial sarcoma
  • Focus Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 02 Jan 2018 New trial record
    • 01 Dec 2017 Results of exposure response analysis published in the Cancer Chemotherapy and Pharmacology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top